1. Home
  2. SCNI vs MYSZ Comparison

SCNI vs MYSZ Comparison

Compare SCNI & MYSZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • MYSZ
  • Stock Information
  • Founded
  • SCNI 2003
  • MYSZ 1999
  • Country
  • SCNI Israel
  • MYSZ Israel
  • Employees
  • SCNI N/A
  • MYSZ N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • MYSZ Computer Software: Prepackaged Software
  • Sector
  • SCNI Health Care
  • MYSZ Technology
  • Exchange
  • SCNI Nasdaq
  • MYSZ Nasdaq
  • Market Cap
  • SCNI 2.8M
  • MYSZ 2.5M
  • IPO Year
  • SCNI N/A
  • MYSZ N/A
  • Fundamental
  • Price
  • SCNI $2.85
  • MYSZ $1.33
  • Analyst Decision
  • SCNI
  • MYSZ Strong Buy
  • Analyst Count
  • SCNI 0
  • MYSZ 1
  • Target Price
  • SCNI N/A
  • MYSZ $3.00
  • AVG Volume (30 Days)
  • SCNI 10.1K
  • MYSZ 3.6M
  • Earning Date
  • SCNI 05-14-2025
  • MYSZ 05-14-2025
  • Dividend Yield
  • SCNI N/A
  • MYSZ N/A
  • EPS Growth
  • SCNI N/A
  • MYSZ N/A
  • EPS
  • SCNI 8.20
  • MYSZ N/A
  • Revenue
  • SCNI $452,000.00
  • MYSZ $8,257,000.00
  • Revenue This Year
  • SCNI N/A
  • MYSZ $35.62
  • Revenue Next Year
  • SCNI N/A
  • MYSZ $12.88
  • P/E Ratio
  • SCNI $0.34
  • MYSZ N/A
  • Revenue Growth
  • SCNI N/A
  • MYSZ 18.02
  • 52 Week Low
  • SCNI $2.23
  • MYSZ $1.05
  • 52 Week High
  • SCNI $8.92
  • MYSZ $9.40
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 34.84
  • MYSZ 45.43
  • Support Level
  • SCNI $2.64
  • MYSZ $1.18
  • Resistance Level
  • SCNI $2.86
  • MYSZ $3.04
  • Average True Range (ATR)
  • SCNI 0.25
  • MYSZ 0.24
  • MACD
  • SCNI -0.06
  • MYSZ 0.04
  • Stochastic Oscillator
  • SCNI 35.93
  • MYSZ 8.02

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About MYSZ My Size Inc.

My Size Inc is a USA based technology company that focuses on the development of an application that assists the consumer to accurately take the measurements of his or her own body to fit clothing without the need to try them on using a smartphone. The purpose of the company's business is to simplify the process of clothing acquisition through the Internet and to significantly reduce the rate of returns of clothing which were acquired through the internet and which are returned to the stores because of ill-fitting. The company generates its revenue through selling products to customers, and licensing cloud-enabled software subscriptions, associated software maintenance and support.

Share on Social Networks: